Home › Bids
› Development and Application of PET and SPECT Imaging Ligands
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
This bid is closed — responses were due May 7, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This grant opportunity (PAR-25-036) from NIH supports the development and application of PET and SPECT imaging ligands as biomarkers. The goal is to advance drug discovery and improve understanding of the pathophysiology of CNS disorders, with an optional clinical trial component.
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.